Home / Market News / $STVN
benzinga Corporate Catalyst Impact 55/100 ● negative

UBS Maintains Neutral on Stevanato Group, Lowers Price Target to $23

Sep 9, 2026, 6:17 PM UTC · Primary ticker $STVN

UBS analyst Dan Leonard has reiterated a Neutral rating on Stevanato Group (STVN) but has reduced the price target from $28 to $23. This indicates a slightly more cautious outlook from UBS regarding the company's future stock performance, despite maintaining a non-negative overall stance.

UBS analyst Dan Leonard has lowered the price target for Stevanato Group (STVN) from $28 to $23, while maintaining a 'Neutral' rating. This action suggests that UBS sees less upside potential for STVN's stock in the near term compared to their previous assessment. For traders, this could signal a slight negative sentiment, potentially leading to short-term downward pressure on the stock as investors adjust their expectations. The long-term implications depend on the underlying reasons for the price target reduction, which are not detailed in this filing but could relate to revised growth forecasts, competitive pressures, or broader market conditions affecting the healthcare sector. The key risk for traders is that other analysts might follow suit, further impacting STVN's valuation.

$STVN negative Price target lowered by UBS
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.